Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial [Phase 3]
Phase 3 clinical trial evaluating laser therapy to treat vaginal dryness in breast cancer survivors; currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Clinical trial update for QuantifyHER, a quantitative immunofluorescence and/or RT-qPCR method to measure HER2 in HER2-low metastatic breast…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers [NA]
ClinicalTrials.gov entry for a trial evaluating a breast cancer treatment decision aid for women 70 and older with low-risk stage I breast c…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors [NA]
This completed clinical trial evaluated strategies to maximize energy and reduce fatigue in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating pembrolizumab with carboplatin and paclitaxel for Stage I triple-negative breast cancer is currently ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer [Phase 4]
A Phase 4 clinical trial is evaluating continuation versus de-escalation of bone-modifying agents in patients with bone metastases from brea…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]
FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies.…
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab [Phase 3]
Phase 3 clinical trial evaluating pembrolizumab versus observation in people with triple-negative breast cancer who achieved pathologic comp…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients [NA]
This clinical trial update reports on germline alterations of tumor susceptibility genes in New York cancer patients across multiple cancer …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer [Phase 2]
A completed Phase 2 study evaluating hetrombopag olamine tablets for thrombocytopenia induced by anti-tumor therapy in patients with advance…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Decision Aid for Women Newly Diagnosed With Breast Cancer [NA]
This entry describes a planned clinical trial evaluating a decision aid for women newly diagnosed with breast cancer to support shared decis…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer [Phase 1]
A completed Phase 1 trial evaluated the combination of capecitabine and cemiplimab in patients with metastatic breast cancer, including horm…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases [NA]
Clinical trial update on a Gallium-68 labeled PSMA PET/CT tracer being studied to differentiate radiation necrosis from tumor progression in…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating dual-target CAR-NK cell therapy for advanced breast cancer, including HER2-positive and triple-negative subt…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies [Phase 4]
A Phase 4 clinical trial sponsored by Hoffmann-La Roche is recruiting to investigate mechanisms of resistance to breast cancer therapies.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: SHAPE Neoadjuvant Chemotherapy Response [Phase 2, Phase 3]
SHAPE is a Phase 2/Phase 3 neoadjuvant chemotherapy trial for stage III breast cancer that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole [Phase 2]
Phase II trial of lenvatinib and pembrolizumab with letrozole in endocrine-resistant, hormone receptor-positive, HER2-negative advanced brea…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Generative AI Patient Education Module for Breast Oncology [NA]
A clinical trial update describes a study evaluating a generative AI patient education module for breast oncology, which is not yet recruiti…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer [Phase 1]
Phase 1 trial PAveMenT is evaluating the combination of palbociclib and avelumab in metastatic AR-positive triple-negative breast cancer and…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy [NA]
Clinical trial update for inspiratory muscle training in breast cancer patients undergoing chemotherapy. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Losartan in Prevention of Radiation-Induced Heart Failure [EARLY_Phase 1]
Early-phase trial evaluating losartan to prevent radiation-induced heart failure in patients with breast cancer; the study has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy [Phase 3]
This is a Phase 3 trial update evaluating fezolinetant for reducing hot flashes in women with breast cancer on hormone therapy; the study is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study evaluating the combination of abemaciclib and elacestrant in participants with ER+/HE…